Chronic Kidney Disease, Dialysis, and Cosmetic Surgery: Why Ibuprofen Is the First Thing to Go, Which Arm Is Off Limits, How Dialysis Day Sets the Surgery Date, and What a Kidney Transplant Means for a Tummy Tuck

The patient is 58, booked for an upper eyelid lift and liposuction of the flanks, and has a plan for recovery that they are quietly proud of. They have read about opioids and want nothing to do with them. They will manage the soreness with ibuprofen, 800 milligrams three times a day, the way they handled a sprained ankle last spring. On the intake form they listed lisinopril and a water pill for blood pressure and metformin for diabetes. Under "kidney problems" they checked no, because nobody had ever used the word kidney with them. Their last blood test, filed in a portal they rarely open, showed an estimated glomerular filtration rate of 41.

That number means stage 3b chronic kidney disease, and the recovery plan the patient built is one of the more reliable ways to injure a kidney in that condition. Kidney disease is not usually a reason to avoid cosmetic surgery. It is a reason to rethink pain control, drug doses, fluid volumes, and where the operation happens, and for patients on dialysis or living with a transplant, it is a reason to plan around a schedule and an anatomy that most cosmetic practices rarely see. What follows is why kidney function belongs on the pre-op checklist, how it reshapes the medication plan, what dialysis changes, what a transplant changes, and what the operation itself needs to account for.

Why kidney function belongs on a cosmetic surgery checklist

The short answer: chronic kidney disease is common, usually silent until late, and concentrated among the older, diabetic, and hypertensive patients who make up a growing share of cosmetic consultations, and its stage changes how nearly every drug used around surgery should be dosed.

The Centers for Disease Control and Prevention estimates that about 35 million American adults, roughly one in seven, have chronic kidney disease, and that as many as nine in ten of them are unaware of it. The disease is defined by the international guideline group KDIGO as abnormal kidney structure or function lasting more than three months, and it is staged largely by the estimated glomerular filtration rate, or eGFR, calculated from a blood creatinine level. Stage 3a runs from 45 to 59, stage 3b from 30 to 44, stage 4 from 15 to 29, and stage 5, kidney failure, falls below 15. The amount of protein in the urine, measured as the albumin-to-creatinine ratio, is staged separately and carries its own risk.

The two leading causes are diabetes and high blood pressure, which is why kidney disease clusters among patients who already need extra planning, as covered in the pieces on blood sugar and cosmetic surgery and high blood pressure before cosmetic surgery. Others include polycystic kidney disease, glomerulonephritis, lupus nephritis (relevant to patients with autoimmune conditions), and long-term exposure to certain medications. Kidney function also declines gradually with age, so a 70-year-old facelift candidate with an eGFR in the fifties is common.

The practical problem is that creatinine is routinely measured and routinely ignored. A basic metabolic panel ordered as part of preoperative testing will show it, and the lab report will usually print the eGFR beside it, but a value of 52 is often filed as "a little low" rather than translated into a stage with consequences. Creatinine also depends on muscle mass, so a small, slender patient can have meaningful kidney disease behind a creatinine that looks normal, and a very muscular one can look worse than they are. When the number matters for a decision, a cystatin C level, a second marker less dependent on muscle, can sharpen the estimate.

The American Society of Anesthesiologists uses kidney disease as one of its own illustrations: in its physical status classification, end-stage kidney disease on regularly scheduled dialysis is listed as an example of ASA class III, a patient with severe systemic disease. That classification matters for where surgery should happen, a point returned to below.

The medication plan: NSAIDs, painkillers, and doses that have to change

The short answer: anti-inflammatory painkillers such as ibuprofen and naproxen are the single most important drug to avoid or strictly limit, several common pain and nerve medications must be dosed down, and morphine and codeine are poor choices once kidney function falls far enough.

Nonsteroidal anti-inflammatory drugs reduce the prostaglandins that keep blood flowing into the kidney when circulation is under strain. In a healthy kidney that matters little. In a kidney with reduced reserve, during the dehydration, blood loss, and low blood pressure that can accompany surgery, it can tip the organ into acute kidney injury. The risk is sharpest in the combination clinicians call the "triple whammy": an NSAID taken together with an ACE inhibitor or ARB (lisinopril, losartan, and their relatives) and a diuretic. That is precisely the patient at the top of this piece. KDIGO advises avoiding NSAIDs entirely at an eGFR below 30 and avoiding prolonged use at higher stages, particularly with those blood pressure drugs. The piece on ibuprofen and NSAIDs after cosmetic surgery explains why these drugs became a cornerstone of modern recovery for healthy patients; in kidney disease, that cornerstone is usually removed, and celecoxib, the selective COX-2 drug sometimes offered as a gentler option, carries the same kidney concern.

That leaves acetaminophen doing more of the work. It is generally considered the safest baseline analgesic in kidney disease at standard doses, and it pairs naturally with the regional nerve blocks, long-acting local anesthetic, and ice described in the piece on opioid-sparing recovery. The catch is that several other staples of opioid-sparing protocols are cleared by the kidneys. Gabapentin and pregabalin, often given before surgery to reduce pain, accumulate in kidney disease and cause sedation, dizziness, and confusion if not dose-reduced; many anesthesiologists simply leave them out for patients with advanced disease.

Among opioids, the differences are large. Morphine is broken down into active metabolites that the kidneys normally remove; when they build up they can cause prolonged sedation, slowed breathing, and muscle twitching, and kidney guidelines generally recommend avoiding morphine in advanced disease. Codeine has a similar problem, and meperidine is avoided altogether. Hydromorphone and oxycodone can be used with dose reduction and closer monitoring, and fentanyl is generally considered among the safer choices in kidney failure. Tramadol requires a longer dosing interval. The prescription a patient goes home with after a cosmetic operation is often a standard one written from a template, so it is worth confirming that someone adjusted it.

Other routine prescriptions need the same check. Many antibiotics, including cefazolin and cephalexin, are dosed by kidney function, as discussed in the piece on antibiotics after cosmetic surgery. Tranexamic acid, increasingly used to reduce bleeding and swelling in facelifts and liposuction, is cleared almost entirely by the kidneys and its dose is reduced in kidney impairment. Metformin is typically held around surgery and when contrast dye is given, and restarted once kidney function is confirmed stable. Even the bowel regimen deserves attention: magnesium-based laxatives such as milk of magnesia and phosphate enemas can cause dangerous mineral buildup in kidney disease, so the advice in the piece on constipation after plastic surgery should lean on polyethylene glycol or senna instead.

Supplements belong in the same conversation. Many herbal products marketed for swelling, bruising, or "detox" have never been studied in kidney disease, and some, including high-dose vitamin C and certain herbal teas, carry their own kidney risks. Potassium-rich salt substitutes are a quieter problem: they can raise blood potassium in patients whose kidneys no longer clear it efficiently, which matters for the anesthesia plan described next.

"

The most dangerous recovery plan for a patient with kidney disease is often the one they chose to be safe: ibuprofen around the clock, taken alongside a blood pressure pill and a diuretic, through the dehydrated days after liposuction.

"

Dialysis patients: the schedule, the fistula arm, and the bleeding question

The short answer: for patients on hemodialysis, surgery is usually scheduled the day after a dialysis session, the arm with the dialysis access is off limits for blood pressure cuffs, needles, and tight garments, and bleeding risk from uremia has to be managed rather than assumed away.

More than half a million Americans receive dialysis, according to the United States Renal Data System, most of them hemodialysis three times a week. Elective cosmetic surgery in this group is uncommon, but it happens, often for problems that dialysis itself creates or reveals: excess skin after weight loss required to qualify for a transplant list, eyelid surgery for vision-limiting skin, or reconstructive work around old access sites.

The calendar comes first. Between sessions, fluid, potassium, and waste products accumulate, so the patient is in their least favorable state just before dialysis. Anesthesiologists generally prefer surgery within a day after a session, when volume and potassium are closest to normal. Surgery directly after dialysis on the same day is less attractive, because patients can be fluid-depleted and prone to low blood pressure, and because heparin is commonly given during the session to keep the circuit from clotting. A potassium level checked on the morning of surgery is standard; a high value can postpone the case, and it affects drug choices, since succinylcholine, a fast-acting muscle relaxant, briefly raises potassium. The nephrologist should know the date, and the next dialysis session after surgery should be booked before the operation, not arranged afterward.

The access arm is the second rule, and it is absolute. An arteriovenous fistula or graft is the patient's lifeline, and it can be lost to a clot. No blood pressure cuff, no IV, no blood draw, no tourniquet, and no tight wrap should be placed on that arm. Many patients with stage 4 disease who will need dialysis in future are also told to protect the veins of their non-dominant arm, under the "save the vein" principle. In practice this means the fistula arm must be marked and announced in the operating room, padded carefully during positioning, and protected from the compression sleeves that follow arm procedures. It also means that a patient with a fistula in one arm who wants an arm lift or arm liposuction, compared in the piece on brachioplasty versus arm liposuction, should expect the access arm to be excluded or treated only after a direct conversation with the vascular surgeon who created it.

The third issue is bleeding. Uremia, the buildup of waste products in kidney failure, impairs platelet function, so a patient can bleed more easily even with a normal platelet count and normal clotting tests. Adequate dialysis improves this, and correcting anemia helps as well, since red cells push platelets toward vessel walls where they do their work. The anemia of kidney disease, often treated with erythropoiesis-stimulating agents and iron, is covered in more detail in the piece on anemia and blood loss before and after cosmetic surgery. For higher-risk cases, desmopressin can temporarily improve platelet function. All of this matters most for operations where bleeding under a skin flap is the signature complication, such as the hematoma after a facelift.

Peritoneal dialysis raises a different set of problems. The catheter exits through the abdominal wall, the abdomen is filled with dialysis fluid for much of the day, and the raised pressure makes hernias common. Liposuction of the abdomen or a tummy tuck in a peritoneal dialysis patient risks injuring the catheter, infecting the peritoneum, or failing at the incision, and most surgeons regard abdominal contouring as off the table while that form of dialysis continues. Hernias found in these patients are a medical repair, not a cosmetic add-on of the kind described in the piece on umbilical hernia repair with a tummy tuck.

Kidney transplant recipients: immunosuppression, drug interactions, and a kidney under the belly

The short answer: a functioning transplant usually means better kidney function than dialysis, but the anti-rejection drugs slow healing, raise infection and skin cancer risk, and interact with common antibiotics, and the transplanted kidney sits in the lower abdomen, exactly where body contouring works.

Roughly a quarter of a million Americans live with a functioning kidney transplant. Many are healthy, active adults who have waited years for a normal life and see cosmetic surgery as part of it, whether that means removing loose skin after the weight loss required for listing, addressing the abdominal scar, or treating the facial fullness left by years of prednisone.

The anti-rejection regimen is the first thing the surgeon must understand. Most recipients take a calcineurin inhibitor, usually tacrolimus, together with mycophenolate and often low-dose prednisone. Some take an mTOR inhibitor, sirolimus or everolimus, and these deserve special attention: they are well documented to impair wound healing and increase wound complications, and transplant centers sometimes switch patients off them before a planned operation. That decision belongs to the transplant team, never to the cosmetic surgeon or the patient alone. Long-term prednisone users may also need stress-dose steroid coverage around surgery, a question the anesthesiologist should settle in advance; it is a different matter from the short courses discussed in the piece on steroids for swelling after plastic surgery.

Drug interactions are where good intentions go wrong. Tacrolimus and cyclosporine levels rise sharply with clarithromycin, erythromycin, fluconazole, and several other common drugs that block the liver enzyme that clears them, and a toxic level can injure the very kidney it is meant to protect. Other drugs, including rifampin and St. John's wort, lower the level and risk rejection. A short prescription written after surgery, an antifungal for a yeast infection under a garment, or an over-the-counter herbal remedy can all disturb a balance the transplant team has spent years maintaining. Any new prescription should be cleared with them, and a tacrolimus level is often rechecked in the week after surgery.

Infection risk is higher in immunosuppressed patients, and the signs can be muted, so a wound that looks only mildly red may be more serious than it appears. The same immune suppression multiplies skin cancer risk: transplant recipients develop squamous cell carcinoma at rates many times those of the general population, so a recipient seeking facial rejuvenation may already be a regular in the dermatology clinic, and the planning described in the piece on Mohs reconstruction for facial skin cancer is directly relevant.

Then there is the anatomy. A transplanted kidney is not placed where the original kidneys sit, deep in the back. It is typically placed in the right or left lower abdomen, in the iliac fossa, just beneath the abdominal wall muscles, with its ureter connected to the bladder. That location overlaps with the lower abdominal liposuction zone and with the dissection of a tummy tuck. Body contouring in a transplant recipient is not forbidden, but it requires knowing exactly where the graft is, usually from the transplant operative note and an ultrasound, staying superficial to the muscle in that region, and avoiding blind cannula passes over it. The surgeon should be able to show the patient where the kidney is before the operation, not after.

The operation itself: fluid, facility, and healing

The short answer: kidney disease narrows the margin for large-volume liposuction and long combined procedures, raises the case for a hospital or hospital-affiliated facility, and slows healing enough that wound care and follow-up should be planned for longer than usual.

Liposuction is, among other things, a fluid exercise. Tumescent technique infuses large volumes of saline containing lidocaine and epinephrine, much of it absorbed into the circulation, while fluid shifts into the treated tissues over the following days. A healthy kidney adjusts. A kidney with limited reserve may not clear excess fluid, and a patient on dialysis cannot clear it at all between sessions, so large-volume liposuction risks fluid overload and fluid in the lungs. The opposite problem, dehydration from fluid lost into tissue, nausea, and poor intake, can trigger acute kidney injury in a patient with moderate disease. Lidocaine itself is broken down by the liver, but some of its active byproducts are cleared by the kidneys, which is one more reason to stay conservative within the limits discussed in the piece on lidocaine toxicity in tumescent liposuction. In practice, patients with advanced kidney disease are usually better served by smaller, staged procedures than by the long combined sessions examined in the piece on how many procedures to combine in one surgery.

The facility matters. An ASA class III patient with dialysis needs, potassium monitoring, and the possibility of an unplanned overnight admission belongs in a setting that can run a potassium level in minutes, arrange dialysis if needed, and admit to a hospital bed without an ambulance ride. That usually means a hospital or a hospital-affiliated surgical center, and it makes the surgeon's admitting rights relevant, as covered in the pieces on outpatient facility accreditation and hospital privileges. Choosing between general anesthesia, sedation, and local anesthesia for a smaller procedure is also partly a kidney question, discussed broadly in the piece on anesthesia choice and the operative plan. An eyelid lift under local anesthesia with light sedation places far less strain on a failing kidney than a five-hour body contouring session.

Imaging can matter too. Contrast dye for a CT scan carries a much smaller kidney risk than once believed, but it is still weighed carefully at low eGFR. Gadolinium, the contrast agent for MRI, has been linked to a rare but serious condition called nephrogenic systemic fibrosis in patients with severe kidney disease; the American College of Radiology considers the newer agents low risk, but the question should be asked by anyone with advanced disease who is having an MRI to check silicone implants, as described in the piece on breast imaging after implants and fat transfer.

Healing is slower. Uremia, low protein levels, anemia, and the diabetes that often accompanies kidney disease all impair the repair of skin and fat, and the risk of wound separation and skin loss rises accordingly, as covered in the pieces on wound dehiscence and skin necrosis after facelift and tummy tuck. A rare but serious condition in dialysis patients, calciphylaxis, causes painful skin and fat breakdown from calcified small blood vessels, and it favors fatty areas such as the abdomen and thighs. It is not a common complication of surgery, but any unusually painful, darkening area of skin in a dialysis patient after an operation deserves prompt evaluation rather than reassurance. Patients losing weight quickly on GLP-1 drugs before surgery should also know that nausea, vomiting, and poor fluid intake on those medications have been linked to acute kidney injury, which is a larger concern when the kidneys start with less reserve.

The honest summary

Chronic kidney disease rarely stands between a patient and a cosmetic operation on its own. It changes the plan, and most of the changes are about drugs. Anti-inflammatory painkillers, so useful for healthy patients, are usually avoided or tightly limited, especially alongside an ACE inhibitor or ARB and a diuretic. Gabapentin and pregabalin are reduced or omitted. Morphine and codeine give way to other opioids at adjusted doses. Antibiotics, tranexamic acid, and even laxatives need a second look. The eGFR on a routine lab report is the number that determines all of it, and it is too often filed and forgotten.

For patients on hemodialysis, surgery is usually scheduled the day after a session, a morning potassium is checked, the nephrologist knows the plan, and the access arm is protected from cuffs, needles, and compression. Bleeding from uremic platelet dysfunction is anticipated and managed. Peritoneal dialysis generally rules out abdominal contouring until it ends.

For transplant recipients, the anti-rejection drugs slow healing, raise infection and skin cancer risk, and interact with common antibiotics and antifungals, so the transplant team reviews every prescription. The new kidney sits in the lower abdomen, and anyone contouring that region should know exactly where.

Across all stages, smaller procedures in a hospital-capable setting, conservative liposuction volumes, and a longer follow-up for healing are the reasonable defaults.

The patient at the top of this piece brought the lab result to the pre-op visit after the surgeon asked to see recent bloodwork. The ibuprofen plan was replaced with scheduled acetaminophen, a long-acting local anesthetic, and a small, adjusted supply of a different opioid that went mostly unused. The diuretic was held the morning of surgery and resumed once they were drinking well. The flank liposuction was kept modest and done as a separate session from the eyelids. Three weeks later, their creatinine was where it had been before, and the only thing that had changed was their reflection.